KRAS is a prognostic biomarker associated with diagnosis and treatment in multiple cancers
Abstract KRAS encodes K-Ras proteins, which take part in the MAPK pathway. The expression level of KRAS is high in…
Da Zhao
Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers
Abstract The CDKN2A (cyclin dependent kinase inhibitor 2A/multiple tumor suppressor 1) gene, also known as the P16 gene, encodes multiple…